About Dash Pharmaceuticals
Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.
- Headquarter Upper Saddle River, United States
- Founders Julie Trendowicz, David Rosen, Nick DiMaio
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Natco Pharma
(Dec 14, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dash Pharmaceuticals
Detailed funding history for Dash Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Dash Pharmaceuticals
Dash Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Natco Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs and finished dosage forms are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for Dash Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dash Pharmaceuticals
Investment portfolio details for Dash Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dash Pharmaceuticals
Detailed financials for Dash Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dash Pharmaceuticals Comparisons
Peer comparison for Dash Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dash Pharmaceuticals
Detailed competitors of Dash Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dash Pharmaceuticals
Complete news archive for Dash Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dash Pharmaceuticals
Dash Pharmaceuticals was founded in 2014.
Dash Pharmaceuticals is headquartered in Upper Saddle River, United States. It is registered at Upper Saddle River, New Jersey, United States.
David Rosen is the current CEO of Dash Pharmaceuticals. They have also founded this company.
Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.
Dash Pharmaceuticals has 1 investor. Key investors include Natco Pharma.